Advanced

   

home about cry contacts  medical info  screening fundraising

counselling

research news

 

Other Cardiac Conditions

Endocardial Fibroelastosis (EFE)
 
Tachycardia

Antibiotic Prophylaxis

Churg-Strauss Syndrome

Right Bundle Branch Block (RBBB)

Kawasaki Disease

 

Endocardial Fibroelastosis (EFE)

What is EFE?

The term ENDOCARDIAL FIBROELASTOSIS (EFE) refers to the thickening of and the replacement of the heart muscle with fibrous tissue. It may be related to viral infections, such as the Coxsackie virus (a form of common cold) or rarely, may have an inherited nature. Doctors feel that the inevitable fatal outcome is triggered by a gene once the virus has been contracted. Unfortunately, it is frequently fatal in affected children.

Top of the page

Genetics

The doctors are, as yet, unable to identify the gene.

Top of the page

Treatment

If identified before death there is no cure for the condition except for anti-arrhythmic drugs as short-term treatment, or in longer term, a heart transplant.

Top of the page

Diagnosis

There is to date no clear information as to how a many children die of this condition, and how many cot deaths are actually caused by EFE and not identified as such.

It is a fact that some parents do not find out the cause of death in their children due to the lack of expertise and investigation carried out at post-mortem.

Top of the page

Tachycardia

Definition

A heart rate exceeding 100 beats per minute.

Classification

A tachycardia can be either physiological (normal response) or pathological. Examples of a physiological tachycardia are during exercise, in pregnancy or in situations of anxiety or excitement (“flight, fright, fight”).

A pathological tachycardia can be due to either a primary cardiac abnormality or a non-cardiac factor. Non-cardiac factors may include anaemia, over-activity of the thyroid gland or chronic liver disease. In these situations the heart itself is normal and is purely responding to increased “demand” due to other abnormalities.

Tachycardia of primary cardiac origin is best classified according to the site of origin of the electrical activity generating the heart rhythm.

There are four chambers in the heart with the two upper chambers (atria) being electrically connected to the lower chambers (ventricles) via an atrio-ventricular node (AV node). The electrical impulse is normally generated by the sino-atrial node (SA node), situated in the right atrium.

Top of the page

Tachycardia can be divided as follows:

  • Tachycardia originating in the atria:

Sinus tachycardia
Atrial tachycardia
Atrial flutter
Atrial fibrillation

  • Tachycardia originating in the AV nodes:  

Re-entry tachycardia

  • Tachycardia originating in the ventricles:

Sustained ventricular tachycardia 
Non-sustained ventricular tachycardia

Top of the page

Symptoms

Individuals with tachycardia can present with a variety of symptoms. Most appear well and unaware of their tachycardia but symptoms can include:  

  • Shortness of breath

  • Palpitations

  • Chest tightness or pain

  • Dizziness or being light-headed

  • Collapse

  • Passing large volumes of urine

Tachycardias of ventricular origin tend to be symptomatic more often.

Top of the page

Management 

If tachycardia is suspected investigations are conducted to diagnose the exact nature, as treatment depends on the type of tachycardia. Tests may include resting ECG, 24 hour ECG recording, exercise ECG and in some rare cases invasive electrophysiological studies.

The patients may also need investigations to look for other heart disease causing tachycardia (e.g. high blood pressure, coronary artery narrowing).

Obviously non-cardiac causes of tachycardia also need to be investigated (e.g. thyroid disease).

Treatment is mostly by medication (e.g. beta-blockers) but in some cases may require radio frequency catheter ablation or implantation of pacemakers or defibrillators. Other factors contributing to heart disease also need addressing.

Top of the page

Antibiotic Prophylaxis

What is Antibiotic Prophylaxis?

This term refers to the use of anitbiotics to prevent the infection of the inner lining of the heart (infective endocarditis), particularly the heart valves.

Antibiotic prophylaxis is used in patients who are considered to be at a high risk of developing infective endocarditis and are undergoing any procedure where infection may be introduced in the blood stream such as a dental procedure or surgery.

Who is at risk?

Individuals at risk include patients with abnormalities of the heart valves (usually detected on physical examination by a heart murmur), prosthetic material within the heart (e.g. metallic heart valve) or ‘holes’ in the heart.

Treatment

The prophylaxis is usually in the form of a single or double large dose of a penicillin antibiotic. If the individual is allergic to penicillin, then erythromycin is used.

Top of the page

Churg-Strauss Syndrome

 

Churg-Strauss syndrome is a rare disease characterised by generalised inflammation of small to medium blood vessels in the body. The syndrome was described by 2 doctors ‘Churg and Strauss’ in 1951.

 

Age at onset - varies from 15-70 years, with mean age being third to fourth decade.

 

Sex - Males are affected slightly more frequently than females

 

Increased levels of certain cells in the blood, which are known as eosinophils are seen. The etiology of the syndrome remains unknown and thought to be autoimmune in nature (meaning that antibodies are produced against ones own body cells). The organs that are usually affected are

 

  • Lungs - asthma, sinusitis and rhinitis

  • Joints - Arthritis

  • Skin - Nodules and rash

  • Heart - Myocarditis (inflammation of hear muscle), Pericarditis (inflammation of covering of the heart), involvement of coronary arteries (arteries which supply blood to heart muscle)

  • Bowels - Inflammation of stomach and intestines presenting as diarrhoea, tummy pain, passing blood in stools

  • Inflammation of nerves

  • Kidneys  

 

Symptoms related to heart are

 

  • Shortness of breath

  • Chest pain

  • Palpitations (awareness of ones own heart beat)

  • Syncope

  • Swelling of legs due to collection of water

  • Very rarely can present as sudden cardiac death due to rhythm disturbances or even myocardial infarction (heart attack)

 

The most common cause of death is from heart involvement in the form of myocardial infarction or heart failure.

 

 

Treatment 

 

The main stay of treatment is with use of steroids either orally as tablets or as injections into veins depending on the severity of the condition. In most of the cases steroids are adequate, in complicated case and in patients who do not respond to steroids more powerful and toxic drugs are used like Cyclophosphamide.

 

Patients should be under the care of specialists depending on the organs involved like cardiologists when heart is involves etc.

 

Top of the page

 

Right Bundle Branch Block (RBBB)

 

What is Right Bundle Branch Block?

Every normal heart is gifted with a natural in-built electrical system. The electrical impulse generated from this system results in beating of the heart.  The electrical system divides into 2 branches (called right and left bundle) at the level of the ventricle (bottom chambers of the heart).

The right bundle stimulates the right ventricle into action and the left bundle stimulates the left ventricle. If there is blockage in any of the branches, it results in the delayed activation of the supplied ventricle. This is reflected on the 12-lead ECG (electrical tracing of the heart), which is interpreted as right or left bundle branch block.

How common is the right bundle branch block?

Right bundle branch block (RBBB) is not an uncommon finding in the general population. The prevalence increases with age, more commonly seen in elderly individuals. RBBB is also not an uncommon finding in young people especially athletes. The prevalence of the condition in young, middle age and elderly individuals is believed to be 0.2%, 0.7% and 11.3% respectively

What is the significance of RBBB on an ECG?

RBBB is usually incidental finding on the ECG, which would have been carried out for another reason. However in the presence of symptoms like chest pain or shortness of breath or syncope, it might signify underlying heart or lung disorders such as

  • Long standing right heart failure
  • Myocardial infarction (heart attack)
  • Occasionally congenital heart conditions (hole in the heart)
  • Long standing lung conditions affecting right side of the heart
  • Pulmonary embolism (clot in the lung)

RBBB seen in elderly individuals without heart problem could be due to the degenerative changes of the right bundle as a part of normal ageing process.

Does RBBB need further investigations and treatment?

As said before, RBBB can be an incidental finding. If there are no symptoms associated, there is no need for further investigations and treatment. If associated with any of the above-mentioned symptoms, then needs further evaluation in the form of echocardiography (ultrasound scan of the heart) and treatment of the conditions diagnosed.

So we suggest that without any of the above symptoms, RBBB is not routinely investigated.

On the other hand left bundle branch block (LBBB) on the ECG almost always suggest underlying heart conditions, which needs to be further investigated.

 

Kawasaki Disease

What is Kawasaki disease?

Kawasaki disease is a children's illness. It's also known as Kawasaki syndrome or mucocutaneous (mu"ko-ku-TA'ne-us) lymph node syndrome. It and acute rheumatic (roo-MAT'ik) fever are the two leading causes of acquired heart disease in children in the United States.

Who gets Kawasaki disease?

About 80 percent of the people with Kawasaki disease are under age five. Children over age eight are rarely affected. The disease occurs more often among boys (over 60 percent) and among those of Asian ancestry. But it can occur in every racial and ethnic group. Over 4,000 cases of Kawasaki disease are being diagnosed annually in the United States. Less than 1 percent of those who get it die.

What happens to those with Kawasaki disease?

The symptoms of Kawasaki disease include...

  • fever   
  • rash   
  • swollen hands and feet   
  • irritation and redness of the whites of the eyes   
  • swollen lymph glands in the neck   
  • irritation and inflammation of the mouth, lips and throat

 

What Causes Kawasaki disease?

 

Doctors don't know what causes Kawasaki disease, but it doesn't seem to be hereditary or contagious. Scientists who've studied it think the evidence strongly suggests it's caused by an infectious agent such as a virus. It's very rare for more than one child in a family to develop Kawasaki disease. Less than 2 percent of children have another attack of Kawasaki disease.

 

In as many as 15 to 25 percent of the children with Kawasaki disease, the heart is affected. The coronary arteries or the heart muscle itself can be damaged.

 

How does Kawasaki disease affect the heart?

 

The coronary arteries are most often affected. Part of a coronary wall can be weakened and balloon (bulge out) in an aneurysm. A blood clot can form in this weakened area and block the artery, sometimes leading to a heart attack. The aneurysm can also burst, but this rarely happens.

 

Other changes include inflammation of the heart muscle (myocarditis) or the sac surrounding the heart (pericarditis). Arrhythmias (abnormal heart rhythms) or abnormal functioning of some heart valves also can occur.

 

Usually all the heart problems go away in five or six weeks, and there's no lasting damage. Sometimes coronary artery damage persists, however.

 

An arrhythmia or damaged heart muscle can be detected using an electrocardiogram (ECG). An echocardiogram (or "echo") is used to look for possible damage to the heart or coronary arteries.

 

How is Kawasaki disease treated?

 

Even though the cause of Kawasaki disease is unknown, certain medicines are known to help. Aspirin is often used to reduce fever, rash, joint inflammation and pain, and to help prevent blood clots from forming. Another medicine, intravenous gamma globulin, can decrease the risk of developing coronary artery abnormalities when given early in the illness.

 

 

Top of the page

 

With special thanks for the Medical Information that has been provided by our team of experts

search & site map

brochure request

my story

links

q & a

donate to CRY


Call us at 01737 363 222 or email us at cry@c-r-y.org.uk

 CRY,
Unit 7, Epsom Downs Metro Centre, Waterfield, Tadworth, Surrey, KT20 5LR
A Company Limited by Guarantee.  Registered in England No. 3052965

Registered Office 35 - 37 Grosvenor Gardens, London SW1 0BY.  Registered Charity No. 1050845
All Copyright reserved by Cardiac Risk in the Young